Williams & Novak’s Goldman Sachs ActiveBeta US Large Cap Equity ETF GSLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
7,441
-96
-1% -$13.3K 0.7% 44
2026
Q1
$950K Sell
7,537
-1,819
-19% -$239K 0.71% 38
2025
Q4
$1.24M Sell
9,356
-170
-2% -$22.3K 0.93% 29
2025
Q3
$1.24M Sell
9,526
-76
-0.8% -$9.56K 0.95% 30
2025
Q2
$1.17M Buy
9,602
+1,115
+13% +$125K 0.99% 31
2025
Q1
$938K Sell
8,487
-2,543
-23% -$294K 0.92% 30
2024
Q4
$1.27M Sell
11,030
-1,451
-12% -$169K 1.23% 24
2024
Q3
$1.41M Buy
12,481
+18
+0.1% +$1.96K 1.32% 24
2024
Q2
$1.33M Buy
12,463
+2,581
+26% +$266K 1.24% 24
2024
Q1
$927K Hold
9,882
1.05% 30
2023
Q4
$927K Buy
+9,882
New +$868K 1.05% 30

Other funds holding GSLC

Williams & Novak's GSLC Position: Q2 2026 in Review

Williams & Novak reduced its Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) stake by 1.3% in Q2 2026, selling an estimated $13.3K and leaving 7,441 shares worth $1.06M. The position accounts for 0.7% of the portfolio, ranked #44.

Williams & Novak first reported a position in GSLC in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.41M in Q3 2024. 107 funds tracked by Wall St. Rank hold GSLC as of Q2 2026.

  • Williams & Novak held 7,441 shares of Goldman Sachs ActiveBeta US Large Cap Equity ETF worth $1.06M as of Q2 2026.
  • Williams & Novak sold 96 Goldman Sachs ActiveBeta US Large Cap Equity ETF shares in Q2 2026, an estimated $13.3K.
  • Goldman Sachs ActiveBeta US Large Cap Equity ETF made up 0.7% of Williams & Novak's portfolio in Q2 2026, its #44 holding.
  • Williams & Novak first reported a position in Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q4 2023 and has held it in 11 quarters since.
  • Williams & Novak's Goldman Sachs ActiveBeta US Large Cap Equity ETF position peaked at $1.41M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta US Large Cap Equity ETF as of Q2 2026.

Based on Williams & Novak's 13F filing for Q2 2026, filed 8 Jul 2026.